Dermatologicals in Portugal

 Published On: Oct, 2017 |    No of Pages: 20 |  Published By: Euromonitor | Format: PDF
Request Free Sample
Dermatologicals is a mature category overall, with most product areas seeing little marketing support or new product development at the end of the review period. Nevertheless, value sales increased in 2017 thanks to price rises. In addition, Bayer Portugal invested in a mass communication campaign over 2016/2017, giving more visibility to the category and driving up overall sales. Dermatologicals will continue to see sales growth constrained by maturity in many areas over the forecast period.

Dermatologicals in Portugal report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the marketís major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Prospects
Dermatologicals Generally A Mature Category
Competition From Other Products Hinders Sales
Greater Consumer Knowledge and Rising Urbanisation Support Self-medication in Certain Categories
Competitive Landscape
Dermatologicals Led by International Companies
Local Brand Halibut Leads the Category Despite the Strength of Multinationals
Competitively-priced Nadiclox Launched by Medinfar
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2012-2017
Table 2 Sales of Dermatologicals by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Dermatologicals: % Value 2013-2017
Table 4 LBN Brand Shares of Dermatologicals: % Value 2014-2017
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2014-2017
Table 6 Forecast Sales of Dermatologicals by Category: Value 2017-2022
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2017-2022
Executive Summary
Portuguese Consumers Are Becoming More Confident Self-medicating
Healthier Lifestyles Stimulate Sales
Consumer Health Competitive Landscape Remains Fragmented
Chemists/pharmacies Faces Increasing Competition
Consumer Health Expected To Record Positive Growth Over the Forecast Period
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 9 Life Expectancy at Birth 2012-2017
Market Data
Table 10 Sales of Consumer Health by Category: Value 2012-2017
Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 1 Research Sources
If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.